Publications en collaboration avec des chercheurs de University of Sassari (14)

2015

  1. Microenvironmental modulation of decorin and lumican in temozolomide-resistant glioblastoma and neuroblastoma cancer stem-like cells

    PLoS ONE, Vol. 10, Núm. 7

2013

  1. Cytoskeletal proteins in the cerebrospinal fluid as biomarker of multiple sclerosis

    Neurological Sciences, Vol. 34, Núm. 2, pp. 181-186

2012

  1. 5-Fluorouracil derivatives: A patent review

    Expert Opinion on Therapeutic Patents, Vol. 22, Núm. 2, pp. 107-123

  2. MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy

    Journal of Translational Medicine, Vol. 10, Núm. 1

2011

  1. E phage gene transfection associated to chemotherapeutic agents increases apoptosis in lung and colon cancer cells

    Bioengineered Bugs, Vol. 2, Núm. 3, pp. 163-167

2009

  1. Low cadmium concentration in whole blood from residents of Northern Sardinia (Italy) with special reference to smoking habits

    Journal of Preventive Medicine and Hygiene, Vol. 50, Núm. 1, pp. 46-52

  2. The cytotoxic activity of the phage E protein suppress the growth of murine B16 melanomas in vitro and in vivo

    Journal of Molecular Medicine, Vol. 87, Núm. 9, pp. 899-911

2006

  1. Differentiation: An encouraging approach to anticancer therapy

    Italian Journal of Anatomy and Embryology, Vol. 111, Núm. 1, pp. 45-64

2005

  1. Indirect immunofluorescence study on the cytoskeleton of normal (FG) and neoplastic (SGS/3A) Cadmium treated fibroblasts

    Italian Journal of Anatomy and Embryology, Vol. 110, Núm. 4, pp. 225-236

2003

  1. Contractile regulatory proteins tropomyosin and troponin-T as indicators of the modulatory role of retinoic acid

    Cells Tissues Organs, Vol. 175, Núm. 1, pp. 25-33

  2. Modulation of HLA class I expression in multidrug-resistant human rhabdomyosarcoma cells

    Neoplasma, Vol. 50, Núm. 2, pp. 91-96

2000

  1. Modulation of myogenic differentiation in a human rhabdomyosarcoma cell line by a new derivative of 5-fluorouracil (QF-3602)

    Japanese Journal of Cancer Research, Vol. 91, Núm. 9, pp. 934-940

1999

  1. GR-891: A novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells

    British Journal of Cancer, Vol. 79, Núm. 5-6, pp. 807-813

1998

  1. Characterization of a new human embryonal rhabdomyosarcoma cell line, RMS-GR

    Japanese Journal of Cancer Research, Vol. 89, Núm. 5, pp. 525-532